Raymond James Financial Services Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.3M | Buy |
6,429
+5,044
| +364% | +$1.81M | ﹤0.01% | 1659 |
|
|
2024
Q2 | $441K | Sell |
1,385
-242
| -15% | -$77.1K | ﹤0.01% | 2624 |
|
|
2024
Q1 | $374K | Sell |
1,627
-74
| -4% | -$17K | ﹤0.01% | 2715 |
|
|
2023
Q4 | $374K | Sell |
1,701
-644
| -27% | -$142K | ﹤0.01% | 2587 |
|
|
2023
Q3 | $530K | Buy |
2,345
+769
| +49% | +$174K | ﹤0.01% | 2291 |
|
|
2023
Q2 | $348K | Buy |
1,576
+677
| +75% | +$149K | ﹤0.01% | 2565 |
|
|
2023
Q1 | $201K | Buy |
899
+55
| +7% | +$12.3K | ﹤0.01% | 2908 |
|
|
2022
Q4 | $235K | Sell |
844
-2,025
| -71% | -$563K | ﹤0.01% | 2753 |
|
|
2022
Q3 | $601K | Buy |
2,869
+141
| +5% | +$29.5K | ﹤0.01% | 2138 |
|
|
2022
Q2 | $643K | Buy |
+2,728
| New | +$643K | ﹤0.01% | 2117 |
|
|
2018
Q2 | – | Sell |
-1,792
| Closed | -$201K | – | 2809 |
|
|
2018
Q1 | $201K | Buy |
1,792
+261
| +17% | +$29.3K | ﹤0.01% | 2252 |
|
|
2017
Q4 | $227K | Buy |
+1,531
| New | +$227K | ﹤0.01% | 2171 |
|